QNCX
#4407
Quince Therapeutics, Inc. - Common Stock
32.6 3 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.18%
Variación mensual
+36.30%
Variación en los últimos 6 meses
+29563.64%
Cambio anual
+1901.84%
Cierres anteriores
32.5 7
Open
33.0 3
Mínimo
32.6 3
Máximo
33.0 3
Volumen
2
Financials
- Market Capitalization 33.19 M
- Employee 38
- Founded 2012
- CEO N/A
- Website www.quincetx.com
- Headquarter California, United States
- FIGI BBG00BTK1DT8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4386 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.30 USD | +9.52% | -15.44% | -49.12% | -75.81% | 38.94 M USD | ||
| 4400 |  LITS Lite Strategy, Inc. - Common Stock | 0.98 USD | -1.01% | -6.67% | +1.03% | -67.11% | 33.34 M USD | ||
| 4425 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.02 USD | 0.00% | -4.67% | +20.00% | -1.92% | 32.07 M USD | ||
| 4427 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.73 USD | +2.82% | +1.39% | -2.67% | -31.13% | 31.75 M USD |